References
- Markus HS, van der Worp HB, Rothwell PM. Posterior circulation ischaemic stroke and transient ischaemic attack: diagnosis, investigation, and secondary prevention. Lancet Neurol. 2013;12(10):989–998.
- Marquardt L, Kuker W, Chandratheva A, et al. Incidence and prognosis of > or = 50% symptomatic vertebral or basilar artery stenosis: prospective population-based study. Brain. 2008;132(4):982–988.
- Gulli G, Marquardt L, Rothwell PM, et al. Stroke risk after posterior circulation stroke/transient ischemic attack and its relationship to site of vertebrobasilar stenosis: pooled data analysis from prospective studies. Stroke. 2013;44(3):598–604.
- Liebeskind DS. Collateral circulation. Stroke. 2003;34:2279–2284.
- Arai K, Jin G, Navaratna D, et al. Brain angiogenesis in developmental and pathological processes: Neurovascular injury and angiogenic recovery after stroke. FEBS J. 2009;276(17):4644–4652.
- Yanev P, Dijkhuizen RM. In vivo imaging of neurovascular remodeling after stroke. Stroke. 2012;43(12):3436–3441.
- Chaturvedi S, Bhattacharya P. Large artery atherosclerosis: Carotid stenosis, vertebral artery disease, and intracranial atherosclerosis. Continuum (Minneap Minn). 2014;20(2):323–334.
- Inamasu J, Guiot BH. Iatrogenic vertebral artery injury. Acta Neurol Scand. 2005;112(6):349–357.
- Parra J, Domingues J, Sargento-Freitas J, et al. Extensive intracranial involvement with multiple dissections in a case of giant cell arteritis. BMJ Case Rep. 2014;2014:bcr2014204130.
- Mason JC. Takayasu arteritis-advances in diagnosis and management. Nat Rev Rheumatol. 2010;6(7):406–415.
- Compter A, van der Worp HB, Schonewille WJ, et al. Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial. Lancet Neurol. 2015;14(6):606–614.
- Markus HS, Larsson SC, Kuker W, et al. Stenting for symptomatic vertebral artery stenosis: the vertebral artery ischaemia stenting trial. Neurology. 2017;89(12):1229–1236.
- Powers WJ. Cerebral hemodynamics in ischemic cerebrovascular disease. Ann Neurol. 1991;29(3):231–240.
- Arnold M, Slezak A, El-Koussy M, et al. Occlusion location of middle cerebral artery stroke and outcome after endovascular treatment. Eur Neurol. 2015;74(5–6):315–321.
- Menon BK, Smith EE, Coutts SB, et al. Leptomeningeal collaterals are associated with modifiable metabolic risk factors. Ann Neurol. 2013;74:241–248.
- Jung S, Wiest R, Gralla J, et al. Relevance of the cerebral collateral circulation in ischaemic stroke: time is brain, but collaterals set the pace. Swiss Med Wkly. 2017;147:w14538.